Cockayne syndrome
| Cockayne syndrome | |
| ICD-10 | Q87.1 |
|---|---|
| ICD-9 | 759.8 |
| DiseasesDB | 2907 |
| eMedicine | ped/424 |
| MeSH | D003057 |
|
WikiDoc Resources for Cockayne syndrome |
|
Articles |
|---|
|
Most recent articles on Cockayne syndrome Most cited articles on Cockayne syndrome |
|
Media |
|
Powerpoint slides on Cockayne syndrome |
|
Evidence Based Medicine |
|
Cochrane Collaboration on Cockayne syndrome |
|
Clinical Trials |
|
Ongoing Trials on Cockayne syndrome at Clinical Trials.gov Trial results on Cockayne syndrome Clinical Trials on Cockayne syndrome at Google
|
|
Guidelines / Policies / Govt |
|
US National Guidelines Clearinghouse on Cockayne syndrome NICE Guidance on Cockayne syndrome
|
|
Books |
|
News |
|
Commentary |
|
Definitions |
|
Patient Resources / Community |
|
Patient resources on Cockayne syndrome Discussion groups on Cockayne syndrome Patient Handouts on Cockayne syndrome Directions to Hospitals Treating Cockayne syndrome Risk calculators and risk factors for Cockayne syndrome
|
|
Healthcare Provider Resources |
|
Causes & Risk Factors for Cockayne syndrome |
|
Continuing Medical Education (CME) |
|
International |
|
|
|
Business |
|
Experimental / Informatics |
Overview
Cockayne syndrome (or "Weber-Cockayne syndrome", or "Neill-Dingwall Syndrome") is a rare, autosomal recessive disorder characterized by growth failure, impaired development of the nervous system, abnormal sensitivity to sunlight (photosensitivity), and premature aging. Hearing loss and eye abnormalities (pigmentary retinopathy) are other common features, but problems with any or all of the internal organs are possible. It is named after English physician Edward Alfred Cockayne (1880-1956).
Forms of Cockayne syndrome
- CS Type I, or the “classic form”, is characterized by normal fetal growth with the onset of abnormalities in the first two years of life. Impairment of vision, hearing, and the central and peripheral nervous system progressively degenerate until death in the first or second decade of life.
- CS Type II, otherwise known as connatal CS, involves very little neurological development after birth. Death usually occurs by age 7.
- CS Type III is rare and is characterized by late onset. It is milder than Type I and Type II.
- Xeroderma-pigmentosum-Cockayne syndrome (XP-CS) occurs when an individual also suffers from Xeroderma pigmentosum, another DNA repair disease. Some symptoms of each disease are expressed.
The condition is also classified genetically as follows:
- Online Mendelian Inheritance in Man (OMIM) 216400 (TYPE A)
- Online Mendelian Inheritance in Man (OMIM) 133540 (TYPE B)
- Online Mendelian Inheritance in Man (OMIM) 216411 (TYPE C)
Causes
Mutations in the ERCC6 and ERCC8 genes cause Cockayne syndrome. The proteins made by the ERCC8 and ERCC6 genes are involved in repairing damaged DNA by the transcription-coupled repair mechanism, particularly the DNA in active genes. If either tr the ERCC6 gene is altered, DNA damage is not repaired. As this damage accumulates, it can lead to malfunctioning cells or cell death, and the signs and symptoms of Cockayne syndrome.
Physical appearance
Small head size, short stature, sunken eyes, "aged" look.
See also
External links
Share and Care Cockayne Syndrome Network
- cockayne at NIH/UW GeneTests
- This article incorporates public domain text from The U.S. National Library of Medicine
Template:Phakomatoses and other congenital malformations not elsewhere classified sr:Кокејнов синдром fi:Cockaynen oireyhtymä